Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to
your Research Finance Administrator. Your can find your Research Finance Administrator at https://www.ucl.ac.uk/finance/research/rs-contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Email: portico-services@ucl.ac.uk
Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
› More search options
Prof Stephanie Schorge
G52
Medical Science Building
UCL
London
WC1E 6BT
Appointment
- Professor of Neuroscience
- Neuro, Physiology & Pharmacology
- Div of Biosciences
- Faculty of Life Sciences
Biography
Stephanie
has been at UCL since 1999, where she joined the Pharmacology Department
as a postdoctoral researcher in single channel
biophysics with Professor David Colquhoun, after which she moved to work
with Professor Dimitri Kullmann at UCL Institute of Neurology (ION). She
obtained her first Fellowship from the Worshipful company of Pewterers
in 2005, and her second fellowship from the Royal
Society in 2010. In 2018 she moved the the UCL School of Pharmacy (SoP) to
become Professor in Translational Neuroscience, and Head of the Research Department of Pharmacology, with the aim of
streamlining the translation of gene therapy research into clinical
applications. In 2021 she moved again and became Head of the Research Department of Neuroscience, Physiology and Pharmacology (NPP), in the Division of Biosciences. She is currently working to build links between NPP, ION and SoP, as well as working with the Translational Research Office to build a virtual pipeline leading from basic science to clinical delivery to support translational research across UCL.
Research Groups
See More
See LessResearch Themes
See More See LessResearch Summary
Stephanie Schorge has a long standing interest in how mutations in ion channels can cause neurological disease, and conversely how manipulating ion channels can be used to treat disease. Recently her work has focused on a developing a portfolio of gene therapy approaches to treat severe drug-refractory epilepsy, and along with several close collaborators this approach is now funded through a first in human trial due to begin recruiting patients in 2022.
Teaching Summary
Teaching includes contributions to the MPharm degree at the School of Pharmacy, as well as lecturing about ion channels and biophysics at the Institute of Neurology and in Neuroscience, Pharmacology and Physiology.
Stephanie holds a Senior Fellowship of the Higher Education Academy.
Additional teaching includes regular contributions to the Plymouth Microelectrode Workshop.
Academic Background
| 1999 | Doctor of Philosophy | Brown University | |
| 1994 | Bachelor of Science | Yale University | |
| ATQ04 - Recognised by the HEA as a Senior Fellow |
